Clinical Trial Update: Weekly Topotecan in the Second-Line Treatment of Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This update reports on a Phase 2 trial evaluating weekly topotecan as second-line therapy for small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Topotecan (topotecan)

Snippet

Sponsor: SCRI Development Innovations, LLC | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED